Evidence map›Paper›PMID 38915643›Full record

ArticlebioRxiv : the preprint server for biology2024

Drug resistance through ribosome splitting and rRNA disordering in mycobacteria.

Soneya Majumdar, Amuliya Kashyap, Ravi K Koripella, Manjuli R Sharma, Kelley Hurst-Hess, Swati R Manjari, Nilesh K Banavali, Pallavi Ghosh, Rajendra K Agrawal

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Soneya MajumdarDivision of Translational Medicine, New York State Department of Health, Albany, NY.
Amuliya KashyapDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY.
Ravi K KoripellaDivision of Translational Medicine, New York State Department of Health, Albany, NY.
Manjuli R SharmaDivision of Translational Medicine, New York State Department of Health, Albany, NY.
Kelley Hurst-HessDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY.
Swati R ManjariDivision of Translational Medicine, New York State Department of Health, Albany, NY.
Nilesh K BanavaliDivision of Translational Medicine, New York State Department of Health, Albany, NY.
Pallavi GhoshDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY.
Rajendra K AgrawalDivision of Translational Medicine, New York State Department of Health, Albany, NY.

Funding

Structural Aspects of Protein Synthesis in the Mammalian MitochondriaR01GM061576 · NIGMS · WADSWORTH CENTER · PI AGRAWAL, RAJENDRA K · 2001 to 2018
$6.4M
Alternative Ribosomes & Antibiotic Tolerance in MycobacteriaR01AI132422 · NIAID · WADSWORTH CENTER · PI RAJENDRA K AGRAWAL, Anil Kumar Ojha · 2017 to 2026
$3.8M
Systematic Discovery and Analysis of Small Proteins and Small ORFs in MycobacteriaR01GM139277 · NIGMS · WADSWORTH CENTER · PI DERBYSHIRE, KEITH M, GRAY, TODD · 2020 to 2023
$2.2M
NIAID NIH HHS R01 AI132422NIGMS NIH HHS R01 GM061576NIGMS NIH HHS R01 GM139277
6 · The paper itself

Abstract

HflX is known to rescue stalled ribosomes and is implicated in antibiotic resistance in several bacteria. Here we present several high-resolution cryo-EM structures of mycobacterial HflX in complex with the ribosome and its 50S subunit, with and without antibiotics. These structures reveal a distinct mechanism for HflX-mediated ribosome splitting and antibiotic resistance in mycobacteria. In addition to dissociating ribosome into two subunits, mycobacterial HflX mediates persistent disordering of multiple 23S rRNA helices to generate an inactive pool of 50S subunits. Mycobacterial HflX also acts as an anti-association factor by binding to pre-dissociated 50S subunits. A mycobacteria-specific insertion in HflX reaches further into the peptidyl transferase center. The position of this insertion overlaps with ribosome-bound macrolides or lincosamide class of antibiotics. The extended conformation of insertion seen in the absence of these antibiotics retracts and adjusts around the bound antibiotics instead of physically displacing them. It therefore likely imparts antibiotic resistance by sequestration of the antibiotic-bound inactive 50S subunits.

Identifiers

PMID38915643
PMCPMC11195266

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.